NYSE · Financial Statements
NeueHealth, Inc. (NEUE) Financial Statements
$6.75
NYSE: NEUE
Market Cap $60.94M
Overview Financials Dividend
NeueHealth, Inc. most recently reported annual revenue of $937.0M, a net loss of $135.0M. Revenue grew at an average annual rate of 27.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024
Revenue $515.0M $1.5B $751.0M $1.2B $937.0M Operating Profit $-170.0M $-344.0M $-369.0M $-577.0M $-107.0M Net Profit $-248.0M $-1.2B $-1.5B $-1.2B $-135.0M EPS $-143.42 $-150.77 $-190.04 $-150.94 $-22.65 Op Margin -33.1% -22.7% -49.1% -49.7% -11.5%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024
Total Assets $1.8B $3.6B $4.7B $1.2B $544.0M Total Liabilities $2.3B $2.3B $3.7B $1.5B $930.0M Cash $488.0M $289.0M $217.0M $87.0M $83.0M Borrowings $28.0M $155.0M $350.0M $370.0M $205.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024
Operating Cash Flow $-57.0M $82.0M $234.0M $-2.7B $-123.0M Investing Cash Flow $-696.0M $-674.0M $-859.0M $2.2B $374.0M Financing Cash Flow $0 $-10.0M $-4.0M $-16.0M $-102.0M Net Cash Flow $-35.0M $573.0M $871.0M $-1.6B $-190.0M Free Cash Flow $-64.0M $52.0M $207.0M $-2.7B $-126.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -2.67 FCF Yield -43.53% Quick Ratio 0.70 Interest Coverage 1.25 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .